Nephros Inc (NEPH) Stock Price, Quote & News

Company Profile

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilitie...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 343 5202

Website: www.nephros.com

Address:

380 Lackawanna Place, South Orange, United States

SvenneKaare Jun. 21 at 2:10 PM

$INLF $LUCY $NEPH $VIVK I’m confident $INLF will gap UP Monday morning. Oversold into closing and topped at 1,28 during AH💪🚀

0 · Reply

Sw1ngb0t Jun. 21 at 1:56 PM

$LUCY $NEPH $INLF $VIVK 3 birds stoned at once list

0 · Reply

topstockalerts Jun. 21 at 6:42 AM

Fridays Top Gainers PT2 $MITQ $PXLW $NEPH $NNNN $GEOS

0 · Reply

topstockalerts Jun. 20 at 10:36 PM

Top Gainers PT2 $MITQ $PXLW $NEPH $NNNN $GEOS

0 · Reply

Senor_Slap_My_Nuts Jun. 20 at 10:27 PM

$NEPH let me guess. they got some contract for the war?

1 · Reply

Senor_Slap_My_Nuts Jun. 20 at 10:27 PM

$NEPH hmmmm

0 · Reply

stockanalysis_ Jun. 20 at 8:50 PM

After Hours Losers: $NXTT $CTOR $GIFT $LGCL $NEPH Keep up with the list here: https://stockanalysis.com/markets/afterhours/?ref=saveontrading

0 · Reply

HaltTradeAlert Jun. 20 at 7:56 PM

$NEPH Halt Time: 15:53:39 Issue Symbol: NEPH Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

0 · Reply

CrayP Jun. 16 at 9:52 PM

$NEPH Good little company that should generate good growth and profitability but good golly what a bush league ”investor day” if thats even what you want to call it. mgmt should attempt short impactful presentations at microcap conferences and 1x1s, which the new team hasn’t even tried. WTF?

0 · Reply

luigiovine May. 25 at 4:49 AM

$NEPH The water filter market is projected to grow from USD 17.55 billion in 2025 to USD 33.96 billion by 2033 at a CAGR of 8.6%. Nephros Inc. offers the lowest annual costs for water purification, thanks to the long lifespan of its filters (up to 6 months) and minimal maintenance Nephros Inc.: Nephros filters use MediSulfone® technology is particularly valued for its ability to retain particles as small as 0.005 microns, offering high protection against biological contaminants. Nephros filters, such as the DSU-D (Dual Stage Ultra Filter), are designed for water purification in dialysis, with a bacteria and endotoxin removal rate exceeding 99.99%. Their nanofiltration technology ensures water purity surpassing AAMI (Association for the Advancement of Medical Instrumentation) standards for dialysis. Additionally, Nephros filters have an extended lifespan (up to 6 months in some applications), reducing operational costs.

2 · Reply

Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC

Nov 9, 2024, 1:37 PM EST - 8 months ago

Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 8 months ago

Nephros Schedules Third Quarter 2024 Financial Results Conference Call

Oct 17, 2024, 9:00 AM EDT - 9 months ago

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

Aug 10, 2024, 1:58 PM EDT - 11 months ago

Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 11 months ago

Nephros Announces Financial Results for Quarter Ended June 30, 2024

Aug 1, 2024, 7:30 AM EDT - 1 year ago

Nephros Schedules Second Quarter 2024 Financial Results Conference Call

Mar 7, 2024, 7:51 PM EST - 1 year ago

Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 4:15 PM EST - 1 year ago

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 29, 2024, 4:30 PM EST - 1 year ago

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Nov 10, 2023, 5:26 AM EST - 1 year ago

Nephros, Inc. (NEPH) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:15 PM EST - 1 year ago

Nephros Announces Results for Quarter Ended September 30, 2023

Nov 1, 2023, 7:30 AM EDT - 1 year ago

Nephros Hires Judy Krandel as Chief Financial Officer

Oct 25, 2023, 7:30 AM EDT - 1 year ago

Nephros Schedules Third Quarter 2023 Financial Results Conference Call

Sep 19, 2023, 4:30 PM EDT - 1 year ago

Nephros to Present at LD Micro Main Event XVI

Aug 9, 2023, 8:13 PM EDT - 2 years ago

Nephros, Inc. (NEPH) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Nephros Announces Results for Quarter Ended June 30, 2023

Jul 26, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules Second Quarter 2023 Financial Results Conference Call

May 24, 2023, 7:30 AM EDT - 2 years ago

Nephros to Present at LD Micro Invitational XIII

May 10, 2023, 4:15 PM EDT - 2 years ago

Nephros Announces Results for Quarter Ended March 31, 2023

May 8, 2023, 7:30 AM EDT - 2 years ago

Nephros Announces CEO Retirement and Succession Plan

Apr 26, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules First Quarter 2023 Financial Results Conference Call

Apr 4, 2023, 7:30 AM EDT - 2 years ago

Nephros Announces Preliminary Results for First Quarter 2023

Mar 8, 2023, 10:28 PM EST - 2 years ago

Nephros, Inc. (NEPH) Q4 2022 Earnings Call Transcript

Mar 8, 2023, 4:15 PM EST - 2 years ago

Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Mar 1, 2023, 4:30 PM EST - 2 years ago

Nephros and Donastar Announce Strategic Partnership

Feb 22, 2023, 4:30 PM EST - 2 years ago

Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call

Jan 11, 2023, 7:30 AM EST - 2 years ago

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

Nov 6, 2022, 2:29 AM EST - 2 years ago

Nephros, Inc. (NEPH) Q3 2022 Earnings Call Transcript

Nov 2, 2022, 4:15 PM EDT - 2 years ago

Nephros Announces Results for Quarter Ended September 30, 2022

Oct 19, 2022, 7:30 AM EDT - 2 years ago

Nephros Third Quarter 2022 Financial Results Conference Call

Oct 12, 2022, 7:30 AM EDT - 2 years ago

Nephros to Present at LD Micro Main Event XV

Oct 11, 2022, 7:30 AM EDT - 2 years ago

Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

Sep 28, 2022, 7:30 AM EDT - 3 years ago

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

Sep 8, 2022, 4:00 PM EDT - 3 years ago

Nephros Appoints Joe Harris to Its Board of Directors

Aug 10, 2022, 9:32 PM EDT - 3 years ago

Nephros, Inc.'s (NEPH) CEO Andy Astor on Q2 2022 Results - Earnings Call Transcript

Aug 10, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended June 30, 2022

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Nephros Second Quarter 2022 Financial Results Conference Call

Jul 6, 2022, 7:30 AM EDT - 3 years ago

Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

May 17, 2022, 7:30 AM EDT - 3 years ago

Nephros Receives FDA 510(k) Clearance for HDF Assist Module

May 7, 2022, 9:16 AM EDT - 3 years ago

Nephros, Inc. (NEPH) CEO Andy Astor on Q1 2022 Results - Earnings Call Transcript

May 4, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended March 31, 2022

Apr 27, 2022, 7:30 AM EDT - 3 years ago

Nephros First Quarter 2022 Financial Results Conference Call

Apr 26, 2022, 7:30 AM EDT - 3 years ago

Nephros Unveils New Branding and Website

Mar 21, 2022, 7:30 AM EDT - 3 years ago

Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Feb 23, 2022, 8:44 PM EST - 3 years ago

Nephros, Inc. (NEPH) CEO Andy Astor on Q4 2021 Results - Earnings Call Transcript

Feb 23, 2022, 4:15 PM EST - 3 years ago

Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results

Feb 9, 2022, 7:30 AM EST - 3 years ago

Nephros Fourth Quarter 2021 Financial Results Conference Call

Jan 13, 2022, 7:30 AM EST - 3 years ago

Nephros Issues 2022 Shareholder Letter

Jan 11, 2022, 7:30 AM EST - 3 years ago

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022

SvenneKaare Jun. 21 at 2:10 PM

$INLF $LUCY $NEPH $VIVK I’m confident $INLF will gap UP Monday morning. Oversold into closing and topped at 1,28 during AH💪🚀

0 · Reply

Sw1ngb0t Jun. 21 at 1:56 PM

$LUCY $NEPH $INLF $VIVK 3 birds stoned at once list

0 · Reply

topstockalerts Jun. 21 at 6:42 AM

Fridays Top Gainers PT2 $MITQ $PXLW $NEPH $NNNN $GEOS

0 · Reply

topstockalerts Jun. 20 at 10:36 PM

Top Gainers PT2 $MITQ $PXLW $NEPH $NNNN $GEOS

0 · Reply

Senor_Slap_My_Nuts Jun. 20 at 10:27 PM

$NEPH let me guess. they got some contract for the war?

1 · Reply

Senor_Slap_My_Nuts Jun. 20 at 10:27 PM

$NEPH hmmmm

0 · Reply

stockanalysis_ Jun. 20 at 8:50 PM

After Hours Losers: $NXTT $CTOR $GIFT $LGCL $NEPH Keep up with the list here: https://stockanalysis.com/markets/afterhours/?ref=saveontrading

0 · Reply

HaltTradeAlert Jun. 20 at 7:56 PM

0 · Reply

CrayP Jun. 16 at 9:52 PM

0 · Reply

luigiovine May. 25 at 4:49 AM

2 · Reply

PenkeTrading May. 23 at 5:49 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Nephros Inc. Is that bullish or bearish? $NEPH #Nephros #RsiOverbought #NASDAQ

0 · Reply

CrayP May. 23 at 3:48 AM

$NEPH Most of the growth from Q1 was due to the conversion to more recurring/programmatic revenue with lumpy emergency response contributing about 2 cents to EPS. I suspect they are at a normalized run rate of 12 cents in EPS growing 30-40% over the next couple of years. Stock still has a ways to go, IMO.

1 · Reply

Senor_Slap_My_Nuts May. 22 at 6:07 PM

$NEPH delayed reaction i see

0 · Reply

CrayP May. 9 at 9:42 PM

$NEPH Results were strong enough to justify the open... just no volume. Stock is too cheap, this will be rectified in a relatively short amount of time.

1 · Reply

Senor_Slap_My_Nuts May. 9 at 6:32 PM

$NEPH lol ruthless how they brought that down

0 · Reply

Senor_Slap_My_Nuts May. 8 at 11:50 PM

$NEPH i'm interested again

0 · Reply

SparkyReturns May. 2 at 8:47 PM

$ICU Dialysis machine companies like Fresenius are watching the AKI study. They may have to buy ICU at a huge premium to make up for future lost dialysis machine revenue. Nephros, Braun, and Baxter may also be interested. One day this will be amazing. Enjoy your weekend! $FMS $BAX $NEPH $DVA

2 · Reply

afterhoursearnings Apr. 3 at 6:29 PM

$NEPH very small float, any real pressure and this explodes

0 · Reply

PenkeTrading Apr. 3 at 7:33 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Nephros Inc. Is that bullish or bearish? $NEPH #Nephros #RsiOverbought #NASDAQ

0 · Reply

Lowlow1 Apr. 1 at 6:30 PM

$NEPH Agmh very good price to jump in at 0.042 has to get to a dollar soon if I post again mybad we are holding over here..,......

0 · Reply

tea_dubz Apr. 1 at 4:55 PM

$NEPH legionnaires is no joke In the Med field right now 👀

0 · Reply

NVDAMillionaire Mar. 28 at 4:37 PM

$NEPH Water filtration tech looking promising. Nephros has solid positioning in medical and commercial markets. Seeing potential for growth, especially with first profitable quarter. Might start a small position to track their progress. balanced analysis of company progress: https://beyondspx.com/article/nephros-neph-a-water-purification-pioneer-navigating-a-transformative-journey

0 · Reply

Market Cap	42.72M
Revenue (ttm)	14.16M
Net Income (ttm)	70,000.00
EPS (ttm)	N/A
PE Ratio	56.86
Forward PE	N/A
Profit Margin	0.49%
Debt to Equity Ratio	0.00

Volume	19,100
Avg Vol	39,500
Day's Range	N/A - N/A
Shares Out	10.60M
Stochastic %K	36%
Beta	1.09
Analysts	Strong Sell
Price Target	$4.75